Tags: biotechbiotechnologyCancerdrug developmentDrug prices
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. | ||
| 2 | Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia | ||
| 3 | John Wilkerson STAT News STAT Washington correspondent. | ||
| 4 | Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile | 2024 PharmaVoice 100s: Biotech Pathfinders - 6 months ago Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future - about 1 year ago Biogen partner NeuroSense seeks a role in the ALS revolution - about 1 year ago A biotech tackles drug discovery with transcription factor know-how - over 1 year ago | |
| 5 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | ||
| 6 | The Conversation Science Alert Science news. Official account. Australia | ||
| 7 | Hannah Thomasy, PhD The Scientist Freelance science writer. PhD. Seattle & Toronto | Better Living Through Algae Biotechnology - 7 months ago DNA Metabarcoding Reveals Hidden Biodiversity - 8 months ago | |
| 8 | Jason Mast STAT News Writing about science, medicine. | ||
| 9 | Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. | STAT+: Biotech incubator Curie.Bio graduates its first startup - over 1 year ago STAT+: Life science investors close nearly $6 billion in new funds - over 1 year ago | |
| 10 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | Five Quick Facts to Know About Biosimilars - 8 months ago |